-
PUBLICATION
2022.11.02
Today, I would like to share with you some wonderful and exciting news! Recently, a client of ours from the National Defense Medical College, Dr. Yasuhiro Takihata, gave a presentation on NASH diagnostics at the 40th Annual Meeting of the Japanese Society of Laser Medicine (JSLSM) and was awarded the Annual Meeting Award for his work.
-
PRODUCTS AND SERVICES
Introduction of our Primary sclerosing cholangitis (PSC) mice model
2022.10.26
Today, I would like to give you a brief introduction into primary sclerosing cholangitis (PSC), as well as our 3,5-Diethoxycarbonyl-1,4-Dihydrocollidine (DDC) mouse model.
-
NEWS RELEASE
The effect of the gut-liver axis dysfunction in liver disease
2022.10.20
Today, I would like to introduce the relationship between Nonalcoholic steatohepatitis (NASH) and the gut.
-
PUBLICATION
Drug Efficacy Study in the STAM™ Model Published in Cells
2022.10.12
SMC is proud to announce that Cellaïon (BEL) has published the results of their study using our STAM™ model in Cells.
-
PUBLICATION
Drug Efficacy Study in the STAM™ Model Published in Gene
2022.10.05
SMC is proud to announce that TSUMURA & CO. (JPN) has published the results of their study using our STAM™ model in Gene.
-
UPCOMING EVENTS
SMC participate The BioJapan Partnering!
2022.09.28
We are pleased to announce that SMC Laboratories will be participating the BioJapan Partnering Event from October 12th (Wed) to 14th (Fri).
-
NEWS RELEASE
Today, September 21th, is World Alzheimer’s Day!
2022.09.21
We recently mentioned World Alzheimer's Month, including World Alzheimer's Day (Previous article), and today we would like to share SMC's thoughts on the development of a medicine for the treatment of Alzheimer's disease.
-
NEWS RELEASE
The importance of the NAFLD activity score and the STAM™ model’s clinical relevance
2022.09.14
In this issue, we would like to introduce the NAFLD activity score (NAS), which is one of the main endpoints used in the development of drug candidates for NASH, and the role it plays in our proprietary STAM™ model.
-
PRODUCTS AND SERVICES
Introducing our Idiopathic Pulmonary Fibrosis (IPF) mouse model
2022.09.07
The outbreak of COVID-19 causes a lot of complications and long-term harm to the patient, especially severe pulmonary fibrosis.
-
NEWS RELEASE
September is World Alzheimer’s Month!
2022.08.31
In recognition of September 21st being World Alzheimer’s Day, why don’t we deepen our understanding of Alzheimer's disease?
-
UPCOMING EVENTS
SMC attend The Biotechgate Digital Partnering!
2022.08.24
We are pleased to announce that SMC Laboratories will be virtually attending the Biotechgate Digital Partnering from August 29th to September 2nd.
-
UPCOMING EVENTS
SMC attend The 8th Taiwan-Japan Pharmaceutical Seminar/Business Matching!
2022.08.17
We are pleased to announce that SMC Laboratories will be virtually attending the 8th Taiwan-Japan Pharmaceutical Seminar/Business Matching on September 2nd.